Activation of the contact system in lethal hypotensive bacteremia in a baboon model

American Journal of Pathology

Volumn 140, Issue 4, 1992, Pages 897-906

  Pixley, Robin A ^a   DeLa Cadena, Raul A ^a   Page, Jimmy D ^a   Kaufman, Nathan ^a   Wyshock, Edward G ^a   Colman, Robert W ^a   Chang, Alan ^b   Taylor Jr , Fletcher B ^b  

^a TEMPLE UNIVERSITY   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; COMPLEMENT; CYTOKINE; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; PREKALLIKREIN; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTERIAL PRESSURE; ARTICLE; BABOON; BREATHING RATE; COMPLEMENT SYSTEM; CONTROLLED STUDY; ESCHERICHIA COLI; HEART RATE; HYPOTENSION; KALLIKREIN KININ SYSTEM; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; STATISTICAL ANALYSIS;

ALPHA-MACROGLOBULINS; ANIMAL; BACTEREMIA; BLOOD PRESSURE; ESCHERICHIA COLI; HYPOTENSION; KALLIKREINS; KININOGENS; PAPIO; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026524251     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Beutler B, Cerami A: Cachectin: more than a tumor necrosis factor. N Engl J Med 1987, 316:379-385
2. Colman RW: The role of plasma proteases in septic shock. N Engl J Med 1989, 320:1207-1209
3. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA: A specific receptor antagonist for interleukm 1 prevents Eschenchia coli-induced shock in rabbits. FASEB J 1991, 5:338-343
4. Carmona RH, Tsao TC, Trunkey DD: The role of prostacylin and thromboxane in sepsis and septic shock. Arch Surg 1984, 119:189-192
5. Kalter ES, Daha MR, ten Cate JW, Verhoef J, Bouma BN: Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis 1985, 151:1019-1027
6. Stevens JH, O'Hanley P, Shapiro JM, Mihm FG, Satoh PS, Collins JA, Raffin TA: Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest 1986, 77:1812-1816
7. Hack CE, Nuijens JH, Felt-Bersma RJF, Schreuder WO, Eerenberg-Belmer AJM, Paardekooper J, Bronsveld W, Thijs LG: Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 1989, 86:20-26
8. Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NNH, Allen IE, Berger HJ, Knatterud GL, LoBuglio AF, Smithe CR, et al: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin, A randomized, double-blind, placebo-controlled trial. N Engl J Med 1991, 324:429-436
9. Smith-Erichsen N, Aasen AO, Gallimore MJ, Amundsen E: Studies on components of the coagulation system in normal individuals and septic shock patients. Circ Shock 1982, 9:491-497
10. Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 1987, 15:923-929
11. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrilio JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989, 321:280-287
12. Rocha E, Silva M, Beraldo WT, Rosenfeld G: Bradykinin, A hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin Am J Physiol 1949, 156:261-273
13. Schmaier AH, Silverberg M, Kaplan AP, Colman RW: Contact activation and its abnormalities. Hemostasis and Thrombosis. Edited by RW Colman, J Hirsh, VJ Marder, and EW Salzman. Philadelphia, PA, J.B. Lippincott Co, 1987, pp 18-38
14. Pixley RA, Schapira M, Colman RW: The regulation of human factor XIIa by plasma proteinase inhibitors. J Biol Chem 1985, 260:1723-1729.
15. Harpel PC, Lewin MF, Kaplan AP: Distribution of plasma kallikrein between C1 inactivator and α2-macroglobulin in plasma utilizing a new assay for α2-macroplobulin-kallikrein complexes. J Biol Chem 1985, 260:4257-4263.
16. 2macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood 1991, 77:2660-2667.
17. Wachtfogel YT, Kucich U, James HJ, Scott CF, Schapira M, Zimmerman M, Cohen AB, Colman RW: Human plasma kallikrein releases neutrophil elastase during blood coagulation J Clin Invest 1983, 72:1672-1677.
18. Hauert J, Nicoloso G, Schleuning WD, Bachmann F, Schapira M: Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis. Blood 1989, 73:994-999
19. Ghebrehiwet B, Silverberg M, Kaplan AP: Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 1981, 153:665-676
20. Morrison DC, Cochrane CG: Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med 1974, 140:797-811
21. Kalter ES, van Dijk WC, Timmerman A, Verhoef J, Bouma BN: Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus. J Infect Dis 1983, 148:682-691
22. Molla A, Yamamoto T, Akaike T, Miyoshi S, Maeda H: Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J Biol Chem 1989, 264:10589-10594
23. Mason JW, Kleeberg U, Dolan P, Colman RW: Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann Intern Med 1970, 73:545-551
24. Wong P, Colman RW, Talamo RC, Babior BM: Kallikrein bradykinin system in chronic alcoholic liver disease. Ann Intern Med 1972, 77:205-209
25. Hirsch EF, Nakajima T, Oshima G, Erdos EG, Herman CM: Kinin system responses in sepsis after trauma in man. J Surg Res 1974, 17:147-153
26. MacLean LD, Mulligan WG, Mclean APH, Duff JH: Patterns of septic shock in man - A detailed study of 56 patients. Ann Surg 1967, 166:543-562
27. Mason DT, Melmon KL: Effects of bradykinin on forearm venous tone and vascular resistance in man. Circ Res 1965, 17:106-113
28. Nies AS, Forsyth RP, Williams HE, Melmon KL: Contribution of kinin to endotoxic shock in unanesthetized Rhesus monkeys. Circ Res 1968, 22:155-164
29. Herman CM, Oshima G, Erdos EG. The effects of adrenocorticosteroid pretreatment on kinin system and coagulation response to septic shock in the baboon. J Lab Clin Med 1974, 84:731-739
30. Kellermeyer RW, Graham RC: Kinins - Possible physiologic and pathologic roles in man. N Engl J Med 1968, 279:754-759
31. Mason JW, Kleeberg U, Dolan P, Colman RW: Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann Intern Med 1970, 73:545-551
32. Weisser A, Clowes GHA Jr, Colman RW, Talamo R: Sepsis and endotoxemia in pigs: A comparison of mortality and pathophysiology. New Aspects of Trasylol Therapy-The Lung in Shock. Edited by GL Haberland, DH Lewis. New York, Schattauer-Verlag, 1973, pp 159-174
33. Robinson JA, Klodyncky ML, Loeb HS, Racic MR, Gunnar RM: Endotoxin, prekallikrein, complement and systemic vascular resistance: Sequential measurements in man. Am J Med 1975, 59:61-67
34. O'Donnell TFJr, Clowes GHAJr, Talamo RC, Colman RW: Kinin activation in the blood of patients with sepsis. Surg Gynecol Obstet 1976, 143:539-545
35. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987, 79:918-925
36. Taylor FBJr, Emerson TEJr, Jordan R, Chang AK, Blick KE: Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock 1988, 26:227-235
37. Creasey AA, Stevens P, Kenney J, Allison AC, Warren K, Catlett R, Hinshaw L, Taylor FB Jr: Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ Shock 1991, 33:84-91
38. Hinshaw LB, Brackett DJ, Archer LT, Beller BK, Wilson MF: Detection of the "hyperdynamic state" of sepsis in the baboon during lethal E. coli infusion. J Trauma 1983, 23:361-365
39. Pixley RA, Colman RW: Purification of human factor XII from plasma using zinc chelate affinity chromatography. Thromb Res 1986, 41:89-98
40. Proctor RR, Rapaport SI: The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961, 36:212-219
41. DeLa Cadena RA, Scott CF, Colman RW: Evaluation of a microassay for human plasma prekallikrein. J Lab Clin Med 1987, 109:601-607
42. Scott CF, Colman RW: A simple and accurate microplate assay for the determination of factor XI in plasma. J Lab Clin Med 1988, 111:708-714
43. Fisher CA, Schmaier AH, Addonizio VP, Colman RW: Assay of prekallikrein in human plasma: Comparison of amidolytic, esterolytic, coagulation, and immunochemical assays. Blood 1982, 59:963-970
44. Murphy EA: Biostatistics in Medicine. The John Hopkins University Press, Baltimore, 1982 pp 329-351.
45. Scott CF, Silver LD, Purdon AD, Colman RW: Cleavage of high molecular weight kininogen by factor XIa in-vitro. J Biol Chem 1985, 260:10856-10863
46. Scott CF, Silver LD, Schapira M, Colman RW: Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. J Clin Invest 1984, 73: 954-962
47. Kleniewski J, Donaldson VH: Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen. J Lab Clin Med 1987, 109:469-479
48. Kleniewski J, Donaldson V: Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot promoting activity. J Exp Med 1988, 167:1895-1907
49. 2macroglobulin: Effects on receptor binding and endocytosis studied in an in-vivo model. Ann NY Acad Sci 1983, 421:457-471
50. Abbink, JJ, Nuijens JH, Eerenberg AJM, Huijbregts CCM, Strack van Schijndel RJM, Thijs LG, Hack CE: Quantification of functional and inactivated α2-macroglobulin in sepsis. Thromb Haemost 1991, 65:32-39
51. Nuijens JH, Huijbregts CCM, Eerenberg-Belmer AJM, Abbink JJ, Strack van Schijndel RJM, Felt-Bersma RJF, Thijs, LG, Hack CE. Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis. Blood 1988, 72:1841-1848
52. Nuijens JH, Eerenberg-Belmer AJM, Huijbregts CCM, Schreuder WO, Felt-Bersma RJF, Abbink JJ, Thijs LG, Hack CE: Proteolytic inactivation of plasma C1 inhibitor in sepsis. J Clin Invest 1989, 84:443-450
53. Cugno M, Nuijens J, Hack E, Eerenberg A, Frangi D, Agostoni A, Circardi, M: Plasma levels of C1-inhibitor complexes and cleaved C1-inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 1990, 85:1215-1220
54. Van der Graaf F, Koedam JA, Bouma BN: Inactivation of kallikrein in human plasma. J Clin Invest 1983, 71:149-158
55. Schapira M, Scott CF, Colman RW: Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest 1982, 69:462-468
56. Ziccardi RJ: Activation of the early components of the classical complement pathway under physiologic conditions. J Immunol 1981, 126:1769-1773
57. Schapira M, Silver LD, Scott CF, Schmaier AH, Prograis LJJr, Curd JG, Colman RW: Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med 1983, 308:1050-1053
58. Pixley RA, DeLa Cadena RA, Kaufman N, Sewell D, Page J, Wyshock E, Colman RW, Chang A, Taylor FBJr: In-vivo use of a monoclonal antibody to factor XII (Hageman Factor) in a lethal hypotensive septicemic baboon model. Blood 1990, 76(10):433a
59. 2 bradykinin receptors FASEB J 1989, 3:2019-2025
60. 7]bradykinin, a bradykinin antagonist, decreases mortality in a rat model of endotoxic shock. Circ Shock 1989, 27:93-101